Covered recipient · General Payments record
JUSTIN LEONADUS YANCEY
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$2,344.09
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $367.81 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $130.49 | 1 |
| Lilly USA, LLC | $63.25 | 2 |
| Ardelyx, Inc. | $57.60 | 2 |
| Otsuka America Pharmaceutical, Inc. | $39.01 | 2 |
| Relypsa, Inc. | $36.49 | 2 |
| AKEBIA THERAPEUTICS INC | $27.22 | 1 |
| Acerta Pharma LLC | $13.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $27.22 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145831501 | CMS |
| Ardelyx, Inc. | $30.64 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146714863 | CMS |
| Ardelyx, Inc. | $26.96 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146714865 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.75 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104290394 | CMS |
| Lilly USA, LLC | $30.59 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135116207 | CMS |
| Lilly USA, LLC | $32.66 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135113368 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.92 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119007301 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.09 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119007303 | CMS |
| Travere Therapeutics, Inc. | $130.49 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149945492 | CMS |
| Vifor Pharma, Inc. | $17.04 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124062041 | CMS |
| Vifor Pharma, Inc. | $19.45 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124065673 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.